Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
2.03B | 1.85B | 1.53B | 1.32B | 1.34B | Gross Profit |
1.01B | 877.90M | 724.30M | 613.60M | 631.30M | EBIT |
367.70M | 321.50M | 284.80M | 252.30M | 245.60M | EBITDA |
476.70M | 411.30M | 401.80M | 354.00M | 320.60M | Net Income Common Stockholders |
268.80M | 234.50M | 244.40M | 203.40M | 184.40M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
142.70M | 169.50M | 157.40M | 134.10M | 106.30M | Total Assets |
3.00B | 2.79B | 2.20B | 1.88B | 1.94B | Total Debt |
795.90M | 766.20M | 432.20M | 390.30M | 481.60M | Net Debt |
653.20M | 596.70M | 274.80M | 256.20M | 375.30M | Total Liabilities |
1.26B | 1.19B | 792.80M | 709.60M | 800.20M | Stockholders Equity |
1.74B | 1.60B | 1.40B | 1.17B | 1.14B |
Cash Flow | Free Cash Flow | |||
333.40M | 195.30M | 189.40M | 226.20M | 196.10M | Operating Cash Flow |
385.00M | 241.20M | 229.40M | 268.40M | 244.90M | Investing Cash Flow |
-287.50M | -369.60M | -134.90M | -65.00M | -276.90M | Financing Cash Flow |
-119.70M | 138.50M | -73.70M | -173.50M | 64.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | £10.49B | 36.48 | 15.48% | 0.79% | 11.94% | 20.48% | |
78 Outperform | £6.77B | 27.60 | 11.21% | 2.15% | 3.13% | 13.36% | |
68 Neutral | £5.90B | 45.61 | 14.56% | 1.32% | 13.59% | 6.14% | |
67 Neutral | £2.06B | 21.08 | 10.72% | 2.62% | 4.71% | 0.43% | |
62 Neutral | $8.11B | 13.34 | 1.17% | 3.02% | 4.16% | -15.14% |
Halma plc announced a transaction involving the grant of a Performance Share Award under the Executive Share Plan to Carole Cran, the Chief Financial Officer Designate. This transaction, involving 54,301 ordinary shares, reflects the company’s commitment to aligning managerial interests with shareholder value, potentially impacting its operational focus and stakeholder confidence.
Halma plc has disclosed a notification in accordance with the Market Abuse Regulation, revealing share transactions by key managerial personnel. Sharmila Nebhrajani, a Non-Executive Director, purchased 187 ordinary shares, while Carole Cran, the Chief Financial Officer Designate, acquired 8,000 shares. These transactions indicate confidence in Halma’s market positioning and may impact stakeholder perceptions positively.
Halma plc has announced a leadership transition with the retirement of Chief Financial Officer (CFO) Steve Gunning, effective March 31, 2025. Carole Cran, an experienced finance leader and current non-executive director at Halma, has been appointed as CFO Designate and will officially assume the role on April 1, 2025. This change aligns with the company’s succession plans, ensuring continued focus on strategic growth and operational excellence. The appointment is expected to bolster Halma’s financial leadership, leveraging Cran’s extensive experience and familiarity with the company’s sustainable growth model. This transition is significant for stakeholders as it underscores Halma’s commitment to maintaining robust governance and financial stewardship.